GEENA EDMONDS: Open Payments
NPI 1700538477 · MONACA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,152 in 128 payments from 13 companies in 2025. Trend: 2023 $1,605 · 2024 $1,951 · 2025 $3,152
Food & beverage: $3,152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $1,146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $417 |
| Vanda Pharmaceuticals Inc. | 13 | $382 |
| Alkermes, Inc. | 9 | $302 |
| Otsuka America Pharmaceutical, Inc. | 12 | $302 |
| Collegium Pharmaceutical, Inc. | 14 | $216 |
| Supernus Pharmaceuticals, Inc. | 8 | $166 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Corium, LLC | 3 | $36 |
| Almatica Pharma LLC | 2 | $36 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, LYBALVI, Jornay PM, RINVOQ, Qelbree.
Industry payments across PA — which companies pay providers there.
